ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Induction therapy"

  • 2022 American Transplant Congress

    Reduction of Rabbit Anti-Thymocyte Globulin Dosing for Induction of Kidney Transplant During the COVID-19 Pandemic

    C. Burrelli1, S. Gundling1, D. Ecabert1, R. Powell1, A. Padiyar1, K. Andreoni1, K. Chavin2, A. Bixby1

    1University Hospitals Cleveland Medical Center, Cleveland, OH, 2University Hospitals Cleveland Medical Center / Case Western Reserve, Cleveland, OH

    *Purpose: Rabbit anti-thymocyte globulin (rATG) is a polyclonal antibody utilized for induction immunosuppression in high immunologic risk kidney transplant recipients. However, the optimal total dose…
  • 2022 American Transplant Congress

    Tacrolimus After Rabbit Antithymocyte Globulin And Infliximab Induction Immunosuppression In Kidney Transplantation

    O. Viklicky1, G. Bold2, O. Bestard3, P. Hruba1, I. Zahradka1, N. M. Otto2, M. Stein2, A. Sefrin2, S. Christakoudi4, P. M. Reinke2

    1Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2Charité, Berlin, Germany, 3Vall d'Hebron, Barcelona, Spain, 4King's College, London, United Kingdom

    *Purpose: Selective targeting of effector/memory T cells as induction immunosuppression has been discussed in kidney transplantation. Confidence-interval-estimation study may help to estimate range of the…
  • 2022 American Transplant Congress

    A Single Center Experience of Simultaneous Heart-Kidney Transplantation

    A. Samra1, A. Mattoo2

    1Nephrology, New York University Langone Transplant Institute, New York, NY, 2New York University Langone Transplant Institute, New York, NY

    *Purpose: Currently there are no UNOS guidelines regarding the selection criteria required for simultaneous heart-kidney transplant recipients (SHKT). As of 2018 our center has begun…
  • 2022 American Transplant Congress

    Costs Associated with Induction Therapy for Pediatric Kidney Transplantation

    N. M. Rodig1, H. Pizzo2, D. Levy Erez3, T. Richardson4, M. Somers1

    1Boston Children's Hospital, Boston, MA, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3Children’s Hospital of Philadelphia, Philadelphia, PA, 4Children's Hospital Association, Lenexa, KS

    *Purpose: Choice of induction agent for pediatric kidney transplantation (KTx) is often based upon patient characteristics and center practice; costs associated with this choice have…
  • 2022 American Transplant Congress

    Fixed-Dose Rituximab for Pre-Transplant DSA in Kidney Transplant Recipients

    K. Progar1, K. Kurwicki2, N. Nesselhauf3, J. Hagopian4, S. January5, H. Wijeweera6, M. McCloskey7, M. Merzkani8, R. Delos Santos9

    1Transplant, Barnes-Jewish Hospital, St. Louis, MO, 2SSM Health Saint Louis University Hospital, Saint Louis, MO, 3Barnes-Jewish Hospital, Edwardsville, IL, 4Pharmacy, University of Michigan, Ann Arbor, MI, 5Pharmacy, Barnes-Jewish Hospital, Saint Louis, MO, 6Washington University, Saint Louis, MO, 7Barnes-Jewish Hospital, St. Louis, MO, 8Washington University, St Louis, MO, 9Transplant, Washington University, St. Louis, MO

    *Purpose: Donor specific antibodies (DSAs) occur in 15-30% of kidney transplant recipients (KTRs) and are associated with rejection and graft loss. Rituximab (RTX), an antiCD20…
  • 2022 American Transplant Congress

    Thymoglobulin Induction Protocol: Quality Improvement Project via Clinical Audit

    S. Mouawad1, J. Dann1, A. Kumar2, S. Rao3

    1University of Virginia Health System, Charlottesville, VA, 2Nephrology, University of Virginia, Charlottesville, VA, 3University of Virginia, Charlottesville, VA

    *Purpose: The aim of our study was to analyze the adequacy of the thymoglobulin (rATG) induction protocol for the expanding and higher complexity kidney transplant…
  • 2022 American Transplant Congress

    Benefits and Risks of Induction Immunosuppression Therapy in Pediatric Liver Transplantation

    T. Bittermann, P. Abt

    University of Pennsylvania, Philadelphia, PA

    *Purpose: To investigate trends in induction therapy use in pediatric liver transplantation (LT) in the U.S. and evaluate the potential benefits and risks of induction…
  • 2022 American Transplant Congress

    A Single-Center’s Outcomes of Combined Heart-Liver Transplantation

    R. W. Lincoln1, K. Kalvakuri2, A. Guha2, A. Bhimaraj2, E. E. Suarez2, A. Saharia3, C. M. Mobley3, F. Amirkhosravi3, J. Krisl1

    1Pharmacy, Houston Methodist Hospital, Houston, TX, 2DeBakey Heart and Vascular Associates, Houston Methodist Hospital, Houston, TX, 3Surgery, Houston Methodist Hospital, Houston, TX

    *Purpose: The purpose of this study was to evaluate rejection outcomes in our combined heart-liver transplant (CHLT) recipients at 6 months.*Methods: This is a retrospective,…
  • 2022 American Transplant Congress

    Intraoperative Kinetics of Pro-Inflammatory Markers and Delayed-Graft Function During Kidney Transplantation

    P. A. Wadsworth, H. L. Stevenson, M. L. Kueht

    University of Texas Medical Branch, Galveston, TX

    *Purpose: Detailed molecular changes associated with allograft reperfusion have been poorly defined and current methods of predicting delayed graft function (DGF) after kidney transplantation are…
  • 2022 American Transplant Congress

    Selective CD28 Blockade Impacts T Cell Differentiation During Hematopoietic Reconstitution Following Lymphodepletion

    J. Habib, D. Liu, R. L. Crepeau, M. E. Wagener, M. L. Ford

    Emory University, Atlanta, GA

    *Purpose: Costimulation blockade targeting the CD28 pathway provides improved long-term transplant survival without the nephrotoxicity of calcineurin inhibitors. However, treatment with the CTLA-4Ig fusion protein…
  • 1
  • 2
  • 3
  • …
  • 31
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences